key: cord-0947527-a9kgr185 authors: Liang, Dandan; Jia, Ruiying; Yu, Jingfen; Wu, Zhen; Chen, Chaoran; Lu, Guangli title: The effect of remote peer support on stigma in patients after breast cancer surgery during the COVID-19 pandemic: A protocol for systematic review and meta-analysis date: 2021-06-18 journal: Medicine (Baltimore) DOI: 10.1097/md.0000000000026332 sha: fe802bd0a4b4f3cf722399571f7dfaa9f4c4c838 doc_id: 947527 cord_uid: a9kgr185 BACKGROUND: Patients after breast cancer surgery have a high sense of stigma due to the formation of surgical scars, loss of breast shape or other reasons, leading to anxiety, depression, and other adverse mental health problems, thus reducing their quality of life. Remote peer support intervention based on telephone, internet or email is low-cost and easy to spread, and protects patients’ privacy, solves the barriers to access that many patients face when attending face-to-face programs. Therefore, remote peer support may be an effective way to reduce stigma and improve mental health in patients after breast cancer surgery during the coronavirus disease 2019 (COVID-19) pandemic. METHODS: Eight databases (PubMed, Embase, Cochrane Library, CNKI, PsycNET, MEDLINE, Psychology & Behavioral Sciences Collection and Web of Science) will be used to select eligible studies that were published from inception to May, 2021. The eligible studies will be screened, extracted and then the methodological quality will be evaluated independently by 2 reviewers. Review manager software version 5.3 software and Stata version 14.0 software will be used for meta-analysis. RESULTS: The results of this study will show the effect of remote peer support on stigma, depression and anxiety in patients after breast cancer surgery during the COVID-19 pandemic and will be submitted to a peer-reviewed journal for publication. CONCLUSION: The results of this study will provide evidence for the effectiveness of remote peer support in patients after breast cancer surgery during the COVID-19 pandemic. PROSPERO REGISTRATION NUMBER: CRD42021255971. Breast cancer is a serious public health problem and a leading cause of cancer death among women. [1] [2] [3] According to the statistics from the World Health Organization (WHO), breast cancer accounts for 11.6% of all types of cancers and 6.6% of global mortality. [4] In modern society, the treatment of breast cancer has entered the era of multidisciplinary comprehensive treatment guided by biological characteristics, including molecular targeted therapy, hormone therapy, chemotherapy, radiotherapy, traditional Chinese medicine therapy, gene therapy, stem-cell therapy, surgery, and so on, [5, 6] among them, surgery is still the preferred method for patients with breast cancer, except for some special patients (poor general condition, serious diseases in main organs, or the elderly are weak and intolerable, etc). [6] However, breast excision or scar formation caused by surgery will damage the integrity and functionality of the body, loss of self-image and sexual dysfunction of the patients, and then produce a high sense of stigma. [7] [8] [9] Stigma refers to the feeling of isolation, rejection, degradation and criticism during a social process or personal experience which influences the outcomes of physical, psychological and social adjustment. [10, 11] Stigma is a major obstacle to postoperative care for patients with breast cancer, [12] and serious stigma will lead to anxiety, depression or other adverse mental health problems, and then affect their quality of life. [13] It has negative effects throughout the whole process from diagnosis to the end of treatment, [12] and to a certain extent, it will hinder patients from actively seeking medical treatment, making them to conceal their conditions and delay treatment. [14] Especially during the coronavirus disease 2019 (COVID-19) pandemic, quarantine and lockdown measures were often used to control the spread of the epidemic, which also limited people's activities to a certain extent, [15] making it more difficult to address the stigma of patients after breast cancer surgery face to face. Therefore, it is necessary to find an effective solution. Peer support refers to a variety of forms that enable people with similar diseases, physical conditions, or experiences to provide substantive help and emotional support to each other, [16] building non-hierarchical reciprocal relationships by sharing similar life experiences with others, the more homogeneous peers, the more likely this support is to lead to understanding, empathy, and mutual help. [17] At present, there are seven successful models of peer support intervention including professional-led group visits with peer exchange; peer-led face-to-face self-management programs; peer coaches; community health workers; support groups; telephone-based peer support; web-and e-mail-based programs. [18] Among them, remote peer support interventions (telephone or web-based peer support) may be more promising than face-to-face interventions. Because they are low-cost and easy to spread, and they address the access barriers faced by many patients when attending face-to-face programs, and many patients prefer relatively anonymous and private forms of communication. [18, 19] Therefore, in the context of the COVID-19 pandemic, when face-to-face peer support intervention is limited to a certain extent, remote peer support may be more able to play its unique advantages and make up for the inconvenience brought by the epidemic to the treatment of stigma in patients after breast cancer surgery. At present, there have been some studies on the effects of remote peer support on mental health problems in people with type 2 diabetes, heart disease, breast cancer, postpartum women, etc. [20] [21] [22] [23] However, there is no meta-analysis or systematic review on remote peer support intervention to improve stigma in patients after breast cancer surgery. Therefore, in order to find an effective way to reduce stigma in patients after breast cancer surgery during the COVID-19 epidemic, this study conducted a meta-analysis of randomized controlled trials on the improvement of stigma in patients after breast cancer surgery based on remote peer support intervention. This systematic review has been registered in PROSPERO CRD42021255971. We strictly abide by the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) guidelines. [24] 2.2. Inclusion criteria for study selection 2.2.1. Types of studies. This study will include randomized controlled trials investigating the effect of remote peer support on patients after breast cancer surgery during the COVID-19 pandemic. Duplicate research reports or insufficient data will be excluded. Patients after breast cancer surgery during the COVID-19 pandemic will be included, regardless of age, gender, educational status or racial restrictions. People with other serious physical diseases (such as stroke, myocardial infarction, or other malignant tumors) will be excluded. In the intervention group, participants received remote peer support based on telephone, internet or email, or in combination with usual care, but peer support intervention are led by non-professionals. The control group included participants who accepted usual care, usual education, etc. The primary outcomes of the study are stigma, the secondary outcome will be depression and anxiety. 2.2.5. Language. Published in English or Chinese. The Relevant abstracts and titles for all studies will be screened and evaluated by 2 independent reviewers against predefined inclusion criteria, then duplicates or ineligible articles will be Liang et al. Medicine (2021) 100: 24 Medicine excluded based on relevant reasons. The third investigator will resolve any disagreement between the 2 reviewers. The process of screening selection is shown in Figure 1 . Two reviewers will independently collect data from all studies based on the data extraction form. The following study information will be recorded: first author, year of publication, country, sample size, participant age, recruitment site, remote peer support intervention duration and mode, outcome measures, specific treatment for the control groups, follow-up time and intervention content. The third investigator will resolve any disagreement between the 2 reviewers. The authors were contacted to obtain missing or unclear data for further analyses. If it fails, we will analyze it based on available data. We will use the tool recommended by the Cochrane Handbook Version 5.1.0 [25] to analyze the risk of bias in the trials from the following seven aspects: random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other bias. Every item will be classified as "Yes" (low risk of bias), "No" (high risk of bias), or "Unclear" (moderate risk of bias). Disagreements in bias classification will be resolved by discussions among the 2 reviewers and, if necessary, through discussions with the authors. The evidence evaluation of all results will be summarized by the suggested assessment, development and assessment (GRADE) method. [26] The level of evidence will be divided into high, moderate, low, and very low quality. If the evaluated trials used different scales to measure the same outcomes, data will be synthesized by using Hedge g of standardized mean difference (SMD) with 95% confidence interval. According to the Cochrane Handbook, Chi-Squared test and I 2 value could be used to evaluate the heterogeneity. I 2 values of 25%, 50%, and 75% are considered as low, moderate, and high heterogeneity, respectively. We will perform funnel plots and visually examine the signs of asymmetry to investigate publication bias, then use Egger test [27] as a formal test of publication bias when the number of the included studies was more than 10 (n ≥ 10). We will enter group means, standard deviations, and the number of participants in review manager software 5.3 and conducted a random-effects model meta-analysis, and Stata14.0 will be used for sensitivity analysis and Egger test. If available, we will conduct subgroup analysis based on different intervention modes, different intervention times, different ages of participants, different countries, and outcome measures. We will use sensitivity analysis to examine the stability of the results by removing individual trials to determine whether the removed study had a particular effect. This work does not require relevant ethical review because there is no data linked to individual patient or animal information. Our research results will be shared and demonstrated through peerreviewed journals. Breast cancer is a serious social and public problem. With the development of medical technology, the cure rate of breast cancer has also increased, [28, 29] but the stigma generated after breast cancer surgery will lead to anxiety, depression and other mental health problems, affecting the quality of life of patients. [8, 9] Remote peer support is a powerful, sustained and affordable form of intervention that has shown unique advantages at this particular time of the COVID-19 pandemic. [18] Research has shown that providing emotional and informational support through peer mentoring and education support has a positive effect on the reduction of stigma in breast cancer survivors. [30] However, there is still no meta-analysis on the effectiveness of remote peer support on stigma in patients after breast cancer surgery. In this paper, we will systematically evaluate whether remote peer support has a positive effect on stigma in patients after breast cancer surgery. We hope that this study will provide evidence for remote peer support to reduce stigma and improve mental health in patients after breast cancer surgery during the COVID-19 pandemic. In addition, personalized interventions can be developed according to the physical and mental characteristics of patients after breast cancer surgery to maximize the role of remote peer support. The purpose of this study was to evaluate the effect of remote peer support on stigma, depression and anxiety in patients after breast cancer surgery during the COVID-19 pandemic. The results may offer hope for reducing mental health problems and improving quality of life in patients after breast cancer surgery. Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients Cancer statistics for African Americans Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries The anti-breast cancer property of physcion via oxidative stress-mediated mitochondrial apoptosis and immune response Awareness and current knowledge of breast cancer Relationship between cancer stigma, social support, coping strategies and psychosocial adjustment among breast cancer survivors The Mediating Effect of Coping Style on Stigma and Marital Quality in Patients Undergoing Radical Breast Cancer Surgery [ying dui fang shi zai ru xian ai gen zhi shu hou huan zhe bing chi gan yu hun yin zhi liang de zhong jie xiao ying yan jiu Status And Influencing Factors of Stigma in Young Breast Cancer Patients [nian qing ru xian ai huan zhe bing chi gan xian zhuang ji qi ying xiang Narrative therapy to relieve stigma in oral cancer patients: a randomized controlled trial Measuring stigma in people with lung cancer: psychometric testing of the cataldo lung cancer stigma scale Exploring stigma as a barrier to cancer service engagement with breast cancer survivors in Kampala Study on Postoperative Stigma and Influencing Factors of Breast Cancer Patients Knowledge and perspectives of breast and cervical cancer screening among female African immigrants in the Washington D.C. metropolitan area Learning about COVID-19-related stigma, quarantine and isolation experiences in Finland Peer support within a health care context: a concept analysis Diabetes control with reciprocal peer support versus nurse care management: a randomized trial Building Peer Support Programs to Manage Chronic Disease: Seven Models for Success. Oakland CA California Health Care Foundation Overview of peer support models to improve diabetes selfmanagement and clinical outcomes Mobile-enhanced peer support for African Americans with type 2 diabetes: a randomized controlled trial Evaluation of a technology-based peersupport intervention program for preventing postnatal depression (part 1): randomized controlled trial The effect of a peer support intervention on early recovery outcomes in men recovering from coronary bypass surgery: a randomized controlled trial A randomized trial of dyadic peer support intervention for newly diagnosed breast cancer patients in Korea Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement The Cochrane Collaboration's tool for assessing risk of bias in randomised trials GRADE: an emerging consensus on rating quality of evidence and strength of recommendations Bias in meta-analysis detected by a simple, graphical test New treatment strategies for the inflammatory breast cancer Survival rate and prognostic factors among Iranian breast cancer patients Evaluating a culturally tailored peermentoring and education pilot intervention among Chinese breast cancer survivors using a mixed-methods approach Medicine (2021) 100:24 www.md-journal